The Fort Worth Press - Who should get paid for nature's sequenced genes?

USD -
AED 3.672504
AFN 65.000368
ALL 81.431326
AMD 361.239406
ANG 1.789785
AOA 918.000367
ARS 1544.046724
AUD 1.452222
AWG 1.8
AZN 1.70397
BAM 1.754002
BBD 2.018116
BDT 124.801578
BGN 1.747831
BHD 0.378548
BIF 2997.982153
BMD 1
BND 1.283978
BOB 12.019192
BRL 5.504904
BSD 1.002018
BTN 94.051388
BWP 13.802968
BYN 3.000673
BYR 19600
BZD 2.015246
CAD 1.41125
CDF 2320.000362
CHF 0.819824
CLF 0.024951
CLP 981.982871
CNY 6.676504
CNH 6.670804
COP 3236.357114
CRC 454.419084
CUC 1
CUP 24.048249
CVE 98.887942
CZK 21.83445
DJF 178.43146
DKK 6.708504
DOP 60.885162
DZD 136.261154
EGP 53.769786
ERN 15
ETB 164.454778
EUR 0.896804
FJD 2.265604
FKP 0.748808
GBP 0.748083
GEL 2.59504
GGP 0.748808
GHS 11.707995
GIP 0.748808
GMD 74.503851
GNF 8874.938344
GTQ 7.657056
GYD 210.062329
HKD 7.84204
HNL 26.930631
HRK 6.76901
HTG 131.321465
HUF 326.000354
IDR 18108.5
ILS 3.18593
IMP 0.748808
INR 93.910504
IQD 1519.035021
IRR 1891353.000352
ISK 122.790386
JEP 0.748808
JMD 159.024259
JOD 0.70904
JPY 158.47504
KES 130.209408
KGS 87.447804
KHR 4082.328147
KMF 442.00035
KPW 899.999961
KRW 1363.803789
KWD 0.31098
KYD 0.83512
KZT 449.127842
LAK 22542.486884
LBP 89728.711717
LKR 333.213757
LRD 170.342137
LSL 16.570826
LTL 2.95274
LVL 0.60489
LYD 6.412269
MAD 9.794718
MDL 17.910408
MGA 4553.159051
MKD 55.203803
MMK 2099.945107
MNT 3601.130253
MOP 8.088606
MRU 40.453791
MUR 47.030378
MVR 15.403739
MWK 1737.500561
MXN 18.62354
MYR 4.061504
MZN 63.903729
NAD 16.570826
NGN 1347.210377
NIO 36.87727
NOK 9.459904
NPR 150.482041
NZD 1.807175
OMR 0.384144
PAB 1.002108
PEN 3.451773
PGK 4.566611
PHP 63.108038
PKR 277.126855
PLN 3.94555
PYG 6263.39626
QAR 3.662795
RON 4.792204
RSD 105.484059
RUB 81.925564
RWF 1478.947132
SAR 3.756342
SBD 8.048583
SCR 13.773553
SDG 601.503676
SEK 9.894504
SGD 1.282704
SHP 0.748923
SLE 22.950371
SLL 20969.504398
SOS 572.620062
SRD 37.583504
STD 20697.981008
STN 21.972109
SVC 8.76732
SYP 13001.999685
SZL 16.565176
THB 33.550369
TJS 9.243442
TMT 3.5
TND 2.998341
TOP 2.40776
TRY 50.141304
TTD 6.795211
TWD 32.775304
TZS 2647.773642
UAH 45.39348
UGX 4098.470921
UYU 40.312094
UZS 11956.414511
VES 896.316404
VND 25582.5
VUV 118.73125
WST 2.787825
XAF 588.264929
XAG 0.019249
XAU 0.00024594347
XCD 2.70255
XCG 1.805838
XDR 0.707052
XOF 588.264929
XPF 106.954845
YER 236.625037
ZAR 16.51943
ZMK 9001.203584
ZMW 20.360522
ZWL 321.999592
SSP 5745.232324
MXV 2.095222
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Harrison--TFWP